Zhongnan Medical Journal Press

Home Results

A total of 46 result was found. Results that relate to Diabetes

Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1275-1284.
2809 times 811 times

Ya-Ping NIU San-Bao CHAI Jing-Zi MA Meng ZHANG Zuo-Xiang LIU Shan-Shan WU Feng SUN

Basal insulin Oral hypoglycemic agents Type 2 diabetes mellitus Poor treatment effect Umbrella review
Details
Influences of dapagliflozin on blood pressure variability and left ventricular mass index in patients with type 2 diabetes mellitus and hypertension

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):413-419.
2582 times 1275 times

Sa-Sa LI Bei-Bei YE Xin LIU Xia-Ling ZHU

Dapagliflozin Type 2 diabetes mellitus Hypertension Blood pressure variability Left ventricular mass index
Details
Establishment of predictive model for cardiovascular complication of diabetes mellitus

Published on New Medicine 2024,34(1):2-13.
3955 times 1249 times

SUN Yuan1 LIU Kuo1 LI Bingxiao1 WEN Fuyuan1 LI Pandi1 YANG Xiaojun1 QU Aibin1 ZHANG Ling1

Diabetes Cardiovascular complication Lasso regression Predictive model
Details
Effects of dapagliflozin on myocardial work and energy metabolism in heart failure with reduced ejection fraction patients without type 2 diabetes mellitus

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):100-108.
2183 times 793 times

LU Qian DENG Yimin YANG Zongwang HUANG He QIN Peng LUO Weilin YE Shaowu

Dapagliflozin Heart failure with reduced ejection fraction Myocardial function Energy metabolism Diabetes
Details
Analysis of medication and glycemic control of patients with type 2 diabetes under chronic disease management in Xi’an pharmacies

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):184-193.
2496 times 713 times

ZHU Xiaoying REN Biqi SU Xinyue LEI Shuang LIN Shuzhi LIU Wei FENG Bianling

Type 2 diabetes Medication Blood glucose control Chronic disease management
Details
Study on the potential molecular mechanism of Ziyabiti tablets on type 2 diabetes based on network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):192-198.
2559 times 1944 times

Maimaiti Simayi Aizezijiang Aierken HU Yan Wusiman Aihaiti

Ziyabiti tablets Type 2 diabetes Network pharmacology Molecular mechanism Quercetin Kaempferol
Details
Factors influencing ketoacidosis in patients with diabetes and urinary tract infection

Published on New Medicine 2024,34(3):276-281.
2077 times 1181 times

LIU Wen XIANG Shiqiang GONG Yaqi YUAN Huabing XU Jin'e

Diabetes mellitus Ketoacidosis Urinary tract infections Risk factors
Details
Study on the application effect of metformin combined with information-motivation-behavioral model intervention in patients with type 2 diabetes

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):431-439.
2511 times 1109 times

YU Li WANG Xiarong ZHANG Huabei WU Huan YIN Qiong HU Liuqing ZHOU Hongyu

Type 2 diabetes Metformin treatment Information-motivation-behavioral model intervention Satisfaction
Details
The efficacy and safety of liraglutide combined with acarbose in the treatment of obese type 2 diabetes mellitus: a meta-analysis

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):491-500.
2501 times 734 times

WANG Zhengdong WU Wei ZHOU Aiming

Liraglutide Acarbose Obesity type 2 diabetes Randomized controlled trial Meta-analysis
Details
Pharmacoeconomic evaluation of glucagon-like peptide-1 receptor agonist combined with metformin in the treatment of type 2 diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):388-401.
3231 times 1298 times

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

Glucagon-like peptide-1 receptor agonist Metformin Type 2 diabetes mellitus Cost-utility Markov model Pharmacoeconomics
Details
Effect of Tanganjianwan combined with abdominal massage on glucose and lipid metabolism and inflammatory factors in patients of metformin treatment with obesity and type 2 diabetes mellitus

Published on Frontiers in Pharmaceutical Sciences 2024,27(4):595-602.
2743 times 845 times

HU Lijuan WAN Jing ZHU Hao

Tanganjianwan Abdominal massage Obesity and type 2 diabetes mellitus Glucose and lipid metabolism Inflammatory factors
Details
Efficacy and safety of glucagon-like peptide 1 receptor agonists in the treatment of overweight or obese patients with type 2 diabetes: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):519-538.
3156 times 792 times

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

Glucagon-like peptide 1 receptor agonists Type 2 diabetes mellitus Obesity or overweight Efficacy Safety Meta-analysis Randomized controlled trial
Details
Clinical observation of omacycline in the treatment of type 2 diabetes mellitus complicated with community-acquired bacterial pneumonia

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):796-801.
3894 times 805 times

ZHAO Liting XIA Jing LIANG Jiamin GU Chao TAO Feng

Omacycline Type 2 diabetes mellitus Community-acquired bacterial pneumonia Clinical efficacy Advese reaction
Details
Comparison of the effectiveness and safety of semaglutide versus dulaglutide for treating type 2 diabetes: a retrospective cohort study utilizing propensity score matching

Published on Chinese Journal of Pharmacoepidemiology 2024,33(6):601-611.
4705 times 1215 times

HE Lanzhi ZHOU Pengxiang HUANG Shulin LIN Chunyan LUO Haikun QI Jianying ZHANG Hongliang CHEN Xiaoyu ZHOU Ganping

Type 2 diabetes Semaglutide Dulaglutide Effectiveness Safety Propensity score matching Generalized estimation equation
Details
Ertugliflozin in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):778-789.
3407 times 676 times

QIN Fang WU Kunrong LIU Chengyu LIU Daihua

Ertugliflozin Type 2 diabetes mellitus Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details